Jemapete Christopher J 4
4 · Gene Biotherapeutics, Inc. · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Jemapete Christopher J
10% Owner
Transactions
- Purchase
Common Stock
2021-03-16$0.04/sh+300,000$11,970→ 3,800,000 total - Purchase
Common Stock
2021-03-17$0.40/sh+200,000$80,400→ 4,000,000 total
Footnotes (2)
- [F1]Represents the weighted average purchase price for two transactions effected on March 16, 2021, with purchase prices per share ranging from $0.0378 to $0.04. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average purchase price for 16 transactions effected on March 17, 2021, with purchase prices per share ranging from $0.0378 to $0.0425. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.